科研路上的得力伙伴——AI科研助手
基金委“反水论文”政策：未来评审将不再单纯以论文数量为衡量标准
AI就要“无底洞式”投入？变化正在发生
发表716篇论文后，学术泰斗遭遇首次撤稿
2025年最新影响因子正式发布！
Correction: Improving the therapeutic efficacy of sorafenib for hepatocellular carcinoma by repurposing disulfiram
Frontiers in oncology. 2026 Feb 18:16:1772315.
Next-generation sequencing for DLBCL patients with early failure after frontline R-CHOP chemo-immunotherapy
Frontiers in oncology. 2026 Feb 18:16:1682952.
Clinicopathological and molecular features of gynecologic perivascular epithelioid cell tumors: a single-center study
妇科血管周上皮样细胞肿瘤的临床病理与分子特征：一项单中心研究
Frontiers in oncology. 2026 Feb 18:16:1769702.
